Strategic Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-6,394
| Closed | -$288K | – | 181 |
|
|
2025
Q3 | $288K | Buy |
6,394
+2
| +0% | +$93 | 0.05% | 162 |
|
|
2025
Q2 | $296K | Buy |
6,392
+2
| +0% | +$98 | 0.06% | 147 |
|
|
2025
Q1 | $390K | Buy |
+6,390
| New | +$372K | 0.08% | 149 |
|
|
2021
Q4 | – | Sell |
-12,033
| Closed | -$712K | – | 197 |
|
|
2021
Q3 | $712K | Sell |
12,033
-4,119
| -26% | -$271K | 0.15% | 123 |
|
|
2021
Q2 | $1.08M | Buy |
16,152
+60
| +0.4% | +$3.91K | 0.28% | 77 |
|
|
2021
Q1 | $1.01M | Buy |
16,092
+1,219
| +8% | +$75.8K | 0.29% | 78 |
|
|
2020
Q4 | $927K | Sell |
14,873
-986
| -6% | -$60.6K | 0.27% | 79 |
|
|
2020
Q3 | $938K | Sell |
15,859
-1,868
| -11% | -$112K | 0.31% | 65 |
|
|
2020
Q2 | $1.06M | Sell |
17,727
-139
| -0.8% | -$8.31K | 0.4% | 53 |
|
|
2020
Q1 | $1.04M | Buy |
17,866
+851
| +5% | +$52K | 0.45% | 51 |
|
|
2019
Q4 | $1.09M | Buy |
17,015
+356
| +2% | +$20.4K | 0.38% | 63 |
|
|
2019
Q3 | $845K | Sell |
16,659
-2,909
| -15% | -$137K | 0.32% | 78 |
|
|
2019
Q2 | $887K | Sell |
19,568
-2,112
| -10% | -$98.4K | 0.34% | 68 |
|
|
2019
Q1 | $1.03M | Sell |
21,680
-1,105
| -5% | -$55K | 0.4% | 64 |
|
|
2018
Q4 | $1.18M | Sell |
22,785
-7,320
| -24% | -$393K | 0.52% | 52 |
|
|
2018
Q3 | $1.87M | Buy |
30,105
+589
| +2% | +$35K | 0.68% | 39 |
|
|
2018
Q2 | $1.63M | Sell |
29,516
-2,932
| -9% | -$158K | 0.66% | 45 |
|
|
2018
Q1 | $2.05M | Sell |
32,448
-1,612
| -5% | -$104K | 0.85% | 36 |
|
|
2017
Q4 | $2.09M | Sell |
34,060
-2,614
| -7% | -$163K | 0.85% | 36 |
|
|
2017
Q3 | $2.34M | Sell |
36,674
-1,134
| -3% | -$66.2K | 1.01% | 32 |
|
|
2017
Q2 | $2.11M | Sell |
37,808
-4,948
| -12% | -$269K | 0.96% | 33 |
|
|
2017
Q1 | $2.33M | Buy |
42,756
+19,023
| +80% | +$1.04M | 1.1% | 27 |
|
|
2016
Q4 | $1.39M | Sell |
23,733
-3,597
| -13% | -$197K | 0.73% | 47 |
|
|
2016
Q3 | $1.47M | Buy |
27,330
+4,957
| +22% | +$318K | 0.83% | 43 |
|
|
2016
Q2 | $1.65M | Sell |
22,373
-1,612
| -7% | -$114K | 0.95% | 37 |
|
|
2016
Q1 | $1.53M | Sell |
23,985
-27,572
| -53% | -$1.74M | 0.87% | 41 |
|
|
2015
Q4 | $3.55M | Buy |
51,557
+656
| +1% | +$43.4K | 2.32% | 9 |
|
|
2015
Q3 | $3.01M | Sell |
50,901
-243
| -0.5% | -$15.4K | 2.09% | 12 |
|
|
2015
Q2 | $3.4M | Buy |
51,144
+12,502
| +32% | +$824K | 2.17% | 9 |
|
|
2015
Q1 | $1.88M | Sell |
38,642
-4,010
| -9% | -$251K | 1.2% | 26 |
|
|
2014
Q4 | $2.52M | Sell |
42,652
-149
| -0.3% | -$8.4K | 1.64% | 17 |
|
|
2014
Q3 | $2.19M | Buy |
42,801
+4,159
| +11% | +$208K | 1.44% | 21 |
|
|
2014
Q2 | $1.88M | Buy |
38,642
+746
| +2% | +$36.8K | 1.2% | 26 |
|
|
2014
Q1 | $1.97M | Buy |
37,896
+532
| +1% | +$28.3K | 1.32% | 23 |
|
|
2013
Q4 | $1.99M | Buy |
37,364
+3,135
| +9% | +$160K | 1.35% | 19 |
|
|
2013
Q3 | $1.58M | Buy |
34,229
+1,403
| +4% | +$61.6K | 1.3% | 26 |
|
|
2013
Q2 | $1.47M | Buy |
+32,826
| New | +$1.43M | 1.32% | 24 |
|
Other funds holding BMY
Strategic Advisors's BMY Position: Q4 2025 in Review
Strategic Advisors sold out of Bristol-Myers Squibb (BMY) in Q4 2025, closing a stake of 6,394 shares — an estimated $288K sold.
Strategic Advisors first reported a position in BMY in Q2 2013 and held it in 37 quarters. The position peaked at $3.55M in Q4 2015. 2,454 funds tracked by Wall St. Rank hold BMY as of Q4 2025.
- Strategic Advisors reported no remaining Bristol-Myers Squibb position as of Q4 2025 after selling out during the quarter.
- Strategic Advisors sold 6,394 Bristol-Myers Squibb shares in Q4 2025, an estimated $288K.
- Strategic Advisors first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 37 quarters.
- Strategic Advisors's Bristol-Myers Squibb position peaked at $3.55M in Q4 2015.
- 2,454 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.
Based on Strategic Advisors's 13F filing for Q4 2025, filed 10 Feb 2026.